Mindray BeneVision Distributed Monitoring System (DMS), Part No. 115-034413-00
FDA Device Recall #Z-0170-2019 — Class II — August 30, 2018
Recall Summary
| Recall Number | Z-0170-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | August 30, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Mindray DS USA, Inc. dba Mindray North America |
| Location | Mahwah, NJ |
| Product Type | Devices |
| Quantity | 5 |
Product Description
Mindray BeneVision Distributed Monitoring System (DMS), Part No. 115-034413-00
Reason for Recall
The firm has identified performance anomalies with the device caused when more than 64 TD60 telemetry transmitters have been connected to a central station. The anomaly causes some ECG waveforms to appear as a flat line at the centralized viewing station and will manifest if more than 64 TD60 transmitters have been connected to a given central station server. Each central station supports only 32 transmitters at a time. For the issue to manifest, the BeneVision DMS needs to be configured to use flexible device assignment, have more than 64 TD60 transmitters, and the workflow must allow 64 TD60s to move around between multiple central stations in the same care area.
Distribution Pattern
Distributed to accounts in CA, CO, FL, MA, NY, PA, PR, TX, and WV.
Lot / Code Information
This potential issue affects BeneVision DMS with software version 03.01.00 to 03.03.00
Other Recalls from Mindray DS USA, Inc. dba Mindray Nort...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0920-2026 | Class II | Hardware configuration of the BeneVision Centra... | Nov 18, 2025 |
| Z-0720-2026 | Class II | Sevoflurane (SEVO) V90 Electronic Vaporizer wit... | Oct 20, 2025 |
| Z-0721-2026 | Class II | Isoflurane (ISO) V90 Electronic Vaporizer with ... | Oct 20, 2025 |
| Z-2622-2025 | Class II | BeneVision N1 Patient Monitor (N1). Part Number... | Aug 15, 2025 |
| Z-2951-2024 | Class II | Isoflurane E_Vap.(Safety Filling adapter): used... | Jul 22, 2024 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.